AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 250: R676-R681, 1986;
0363-6119/86 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weick, B. G.
Right arrow Articles by Ritter, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weick, B. G.
Right arrow Articles by Ritter, S.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 250, Issue 4 676-R681, Copyright © 1986 by American Physiological Society


ARTICLES

Dose-related suppression of feeding by intraportal glucagon infusion in the rat

B. G. Weick and S. Ritter

Continuous intraportal infusion of pancreatic glucagon during a feeding test conducted in the dark phase of the circadian photoperiod produced a dose-related suppression of feeding in rats. At the end of the 30 min of infusion, food intake was suppressed 10% at the infusion rate of 0.33 micrograms X kg-1 X min-1 and 45% at the highest infusion rate studied (100 micrograms X kg-1 X min-1). At infusion rates of 33 and 100 micrograms X kg-1 X min-1, the suppression of cumulative intake persisted for 30 min after the termination of the infusion, but no effect on 24-h intake was observed. Glucagon's glycemic effects were measured for two glucagon doses (1 and 10 micrograms X kg-1 X min-1) in the absence of food using a paradigm similar to that used for the feeding tests. In contrast to the suppression of food intake, the hyperglycemic effects of glucagon were not dose related for the two doses tested. The hyperglycemia was similar in magnitude 5 min after the start of the infusion at both infusion rates. Subsequently, plasma glucose concentrations declined more rapidly at the higher than at the lower glucagon dose. This difference in the effect of glucagon on glucose disposal may be important for glucagon's satiating effect.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online